previously several years, the UK has witnessed a revolution in clinical bodyweight‑reduction treatment options — from your introduction of semaglutide (Wegovy®) into the rising recognition of tirzepatide (Mounjaro®). Now, A further identify is drawing awareness in the two scientific and public he